Trailing-twelve-month (TTM) revenue is $381.04 Million with a year-over-year growth of (7.54%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $94,295,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $101,058,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2026Period ended 2026-03-31 | $85,454,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $100,233,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $381,040,000 |
Current P/S: $218,676,180 market capitalization ÷ $381,040,000 TTM revenue = 0.57x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:10:15.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $100.23M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:11:58.334Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Professional Services | N/A | N/A | N/A | N/A | $13M | $10M |
| Research Revenue | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $23M | $27M | $27M | $24M | $21M | $22M |
| CANADA | $14M | $17M | $21M | $16M |
$381.04M
$381.04 Million
(7.54%)
vs. $412.11M a year ago (TTM)
(4.17%)
5 Year compound annual growth rate
1 Year
(7.54%)
3 Year
(9.48%)
5 Year
(4.17%)
10 Year
+1.73%
15 Year
+2.42%
20 Year
+4.12%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $396.89M | ($35.58M) | (8.23%) |
| 2024 | $432.47M | ($48.31M) | (10.05%) |
| 2023 | $480.78M | ($57.01M) | (10.60%) |
| 2022 | $537.79M | +$43.47M | +8.79% |
| 2021 | $494.31M | +$45.33M | +10.10% |
| 2020 |
TTM Growth
(7.54%)
3-Year CAGR
(9.48%)
5-Year CAGR
(4.17%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:11:58.334Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $334M |
| $317M |
| $296M |
| Research Services | $294M | $325M | $354M | N/A | N/A | N/A |
|---|
| Software | N/A | N/A | N/A | N/A | $1M | $1M |
|---|
| $11M |
| Europe Excluding United Kingdom | $35M | $41M | $37M | $38M | $38M | $37M |
|---|
| Other Country | $5M | $5M | $8M | $8M | $9M | $7M |
|---|
| UNITED STATES | $356M | $382M | $426M | $373M | $334M | $304M |
|---|
| $448.98M |
| ($12.71M) |
| (2.75%) |
| 2019 | $461.70M | +$104.12M | +29.12% |
| 2018 | $357.57M | +$19.90M | +5.89% |
| 2017 | $337.67M | +$11.58M | +3.55% |
| 2016 | $326.10M | +$12.37M | +3.94% |
